Changing the course: the NHS's first treatment to delay type 1 diabetes

NICE Talks by NICE Talks

NICE has recommended teplizumab for NHS use — the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years. In this episode, we speak to Lucy Chambers, Head of Research Impact...View more